Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Proteasomes are critical drug targets for hematological cancers and autoimmune diseases.
• Existing proteasome inhibitors target specific catalytic subunits (β1c, β1i, β2c, β2i, β5c, β5i).
• Development of selective assays is crucial for understanding proteasome function and inhibitor efficacy.

Purpose of the Study:

• To design and synthesize novel fluorogenic substrates.
• To enable selective measurement of individual proteasome catalytic subunit activities.
• To expand the research toolbox for proteasome studies.

Main Methods:

• Modification of mechanism-based proteasome inhibitors by replacing electrophiles with fluorogenic leaving groups.
• Synthesis of novel fluorogenic substrates based on oligopeptide recognition elements.
• Assay development to measure proteasome activity in Raji cell lysates and purified 20S proteasomes.

Main Results:

• Effective fluorogenic substrates were identified for β1c, β1i, β2c, and β5i subunits.
• Substrates reported on the catalytic activity targeted by parent inhibitors.
• Low activity was observed for β5c and β2i subunit-selective substrates, indicating limitations.

Conclusions:

• New subunit-selective fluorogenic substrates were successfully developed for key proteasome components.
• These substrates enhance the ability to study individual proteasome activities.
• The findings contribute valuable tools for proteasome-targeted therapeutic research.